Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

Information, Expiry & Status of FDA Orange Book Patents covering Ertugliflozin L-Pyroglutamic Acid

Client Email

Product

Ertugliflozin L-Pyroglutamic Acid
US Patents

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

Bora Pharmaceuticals- Making success more certain.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

Contact Supplier

Axplora- The partner of choice for complex APIs.

Contact Supplier

Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

Contact Supplier

Ertugliflozin L-Pyroglutamic Acid

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

11 API Suppliers, 7 USDMF, 2 KDMF, 7 NDC API, 7 Listed Suppliers, $ API Reference Price

11 API Suppliers
7 USDMF
2 KDMF
7 NDC API
7 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

PRICE INFORMATION

API Reference Price, API Exports

API Reference Price
API Exports

INTERMEDIATES

3 API Suppliers

3 API Suppliers

FINISHED DOSAGE FORMULATIONS

26 FDF Dossiers, 14 FDA Orange Book, 6 Europe, 6 Listed Dossiers

26 FDF Dossiers
14 FDA Orange Book
6 Europe
6 Listed Dossiers

RELATED EXCIPIENT COMPANIES

1 Minakem, 2 SPI Pharma, 10 DKSH, 2 Jai Radhe Sales, 5 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 12 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 2 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 20 BASF, 10 Corel Pharma Chem, 6 DFE Pharma, 8 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 30 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 12 Microlex e.U, 1 NEWEDGE Overseas, 3 Novo Excipients, 5 Pharmatrans-Sanaq, 5 Pluviaendo, 5 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 12 Roquette, 6 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 11 Sigachi Industries, 2 The Dow Chemical Company, 2 Ulanqab Kema New Material, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

62 Fillers, Diluents & Binders, 47 Coating Systems & Additives, 40 Disintegrants & Superdisintegrants, 35 Direct Compression, 25 Granulation, 24 Controlled & Modified Release, 20 Lubricants & Glidants, 16 Thickeners and Stabilizers, 13 Co-Processed Excipients, 11 Solubilizers, 10 Film Formers & Plasticizers, 8 Chewable & Orodispersible Aids, 6 Taste Masking, 5 Empty Capsules, 5 Coloring Agents, 4 Parenteral, 4 Vegetarian Capsules, 3 API Stability Enhancers, 3 Rheology Modifiers, 2 Emulsifying Agents, 2 Topical, 1 Surfactant & Foaming Agents

62 Fillers, Diluents & Binders
47 Coating Systems & Additives
40 Disintegrants & Superdisintegrants
35 Direct Compression
25 Granulation
24 Controlled & Modified Release
20 Lubricants & Glidants
16 Thickeners and Stabilizers
13 Co-Processed Excipients
11 Solubilizers
10 Film Formers & Plasticizers
8 Chewable & Orodispersible Aids
6 Taste Masking
5 Empty Capsules
5 Coloring Agents
4 Parenteral
4 Vegetarian Capsules
3 API Stability Enhancers
3 Rheology Modifiers
2 Emulsifying Agents
2 Topical
1 Surfactant & Foaming Agents

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 25 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
25 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 6 Finished Drug Prices

1 US Medicaid Prescriptions
6 Finished Drug Prices

MARKET PLACE

4 APIs

4 APIs

PATENTS & EXCLUSIVITIES

24 US Patents, 8 US Exclusivities

24 US Patents
8 US Exclusivities

$ API Ref.Price (USD/KG) : 7,428 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

24 All

01 24MSD SUB MERCK

filter Patent Number Reset all filters

24 All

01 27326708

02 27326708*PED

03 88080580

04 69308204

05 29439901

06 49439902

filter API Patent Reset all filters

24 All

01 10Y

02 14Blank

filter FDF Patent Reset all filters

24 All

01 16Y

02 8Blank

filter Expiration Date Reset all filters

24 All

01 22026-11-24

02 22027-05-24

03 82030-07-13

04 122030-10-21

US Patents
US Exclusivities

Product Main Page

01

MSD SUB MERCK

ERTUGLIFLOZIN; METFORMIN HYDROCHLORIDE

Luxepack

Not Confirmed

MSD SUB MERCK

Luxepack

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-10-21

ERTUGLIFLOZIN; METFORMIN HYDROCHLORIDE

US Patent Number : 9439902

Drug Substance Claim :

Drug Product Claim :

Application Number : 209806

Patent Use Code : U-2214

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-10-21

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

MSD SUB MERCK

ERTUGLIFLOZIN; METFORMIN HYDROCHLORIDE

Luxepack

Not Confirmed

MSD SUB MERCK

Luxepack

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-07-13

ERTUGLIFLOZIN; METFORMIN HYDROCHLORIDE

US Patent Number : 8080580

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 209806

Patent Use Code : U-2214

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-07-13

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

MSD SUB MERCK

Luxepack

Not Confirmed

MSD SUB MERCK

Luxepack

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-07-13

ERTUGLIFLOZIN

US Patent Number : 8080580

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 209803

Patent Use Code : U-2214

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-07-13

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

MSD SUB MERCK

ERTUGLIFLOZIN; SITAGLIPTIN PHOSPHATE

Luxepack

Not Confirmed

MSD SUB MERCK

Luxepack

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-11-24

ERTUGLIFLOZIN; SITAGLIPTIN PHOSPHATE

US Patent Number : 7326708

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 209805

Patent Use Code : U-2214

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-11-24

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

MSD SUB MERCK

ERTUGLIFLOZIN; SITAGLIPTIN PHOSPHATE

Luxepack

Not Confirmed

MSD SUB MERCK

Luxepack

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-07-13

ERTUGLIFLOZIN; SITAGLIPTIN PHOSPHATE

US Patent Number : 8080580

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 209805

Patent Use Code : U-2214

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-07-13

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

MSD SUB MERCK

ERTUGLIFLOZIN; SITAGLIPTIN PHOSPHATE

Luxepack

Not Confirmed

MSD SUB MERCK

Luxepack

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-11-24

ERTUGLIFLOZIN; SITAGLIPTIN PHOSPHATE

US Patent Number : 7326708

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 209805

Patent Use Code : U-2214

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-11-24

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

MSD SUB MERCK

ERTUGLIFLOZIN; METFORMIN HYDROCHLORIDE

Luxepack

Not Confirmed

MSD SUB MERCK

Luxepack

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-10-21

ERTUGLIFLOZIN; METFORMIN HYDROCHLORIDE

US Patent Number : 9439902

Drug Substance Claim :

Drug Product Claim :

Application Number : 209806

Patent Use Code : U-2214

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-10-21

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

MSD SUB MERCK

ERTUGLIFLOZIN; METFORMIN HYDROCHLORIDE

Luxepack

Not Confirmed

MSD SUB MERCK

Luxepack

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-07-13

ERTUGLIFLOZIN; METFORMIN HYDROCHLORIDE

US Patent Number : 8080580

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 209806

Patent Use Code : U-2214

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-07-13

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

MSD SUB MERCK

Luxepack

Not Confirmed

MSD SUB MERCK

Luxepack

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-07-13

ERTUGLIFLOZIN

US Patent Number : 8080580

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 209803

Patent Use Code : U-2214

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-07-13

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

MSD SUB MERCK

ERTUGLIFLOZIN; SITAGLIPTIN PHOSPHATE

Luxepack

Not Confirmed

MSD SUB MERCK

Luxepack

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-07-13

ERTUGLIFLOZIN; SITAGLIPTIN PHOSPHATE

US Patent Number : 8080580

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 209805

Patent Use Code : U-2214

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-07-13

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2
3

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?